MRVI(Maravai LifeSciences Holdings, Inc.) · 财务报表

MRVI(Maravai LifeSciences Holdings, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$799.24M$883.00M$288.94M$259.19M$185.74M
毛利润$658.68M$714.04M$140.20M$108.31M$33.99M
营业利润$554.64M$574.22M−$31.65M−$235.62M−$215.27M
净利润$182.04M$220.21M−$119.03M−$144.85M−$130.77M
经营现金流$368.57M$535.98M$126.22M$7.46M−$57.57M
自由现金流$353.72M$518.89M$60.67M−$22.19M−$70.72M
摊薄每股收益——$-0.90$-1.05$-0.90

Maravai LifeSciences Holdings, Inc. MRVI